reboxetine has been researched along with cirazoline in 1 studies
Studies (reboxetine) | Trials (reboxetine) | Recent Studies (post-2010) (reboxetine) | Studies (cirazoline) | Trials (cirazoline) | Recent Studies (post-2010) (cirazoline) |
---|---|---|---|---|---|
626 | 193 | 184 | 226 | 0 | 24 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cremers, TI; Folgering, J; Rea, K; Westerink, BH | 1 |
1 other study(ies) available for reboxetine and cirazoline
Article | Year |
---|---|
Alpha1-adrenoceptors modulate citalopram-induced serotonin release.
Topics: Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic Uptake Inhibitors; Animals; Brain; Citalopram; Extracellular Space; Hippocampus; Imidazoles; Male; Morpholines; Prazosin; Prefrontal Cortex; Raphe Nuclei; Rats; Rats, Wistar; Reboxetine; Receptors, Adrenergic, alpha-1; Selective Serotonin Reuptake Inhibitors; Serotonin | 2010 |